Epratuzumab targeting of CD22 affects adhesion molecule expression and migration of B-cells in systemic lupus erythematosus

Overview of attention for article published in Arthritis Research & Therapy, November 2010

Altmetric Badge

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 82 Dimensions

Readers on

mendeley: 52 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

Crosslinking of CD22 by epratuzumab triggers BCR signaling and caspase-dependent…

Grant US-9757458-B2

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.